Showing 1-17 of 17 for: Decision Support Tools > Oncology: Risk 
- Breast CA: risk of cancer in women with breast symptoms
LOE 1a
Decision Support Tools, 2-Jul-2015
Based on the results of Galvin R, Joyce D, Downey E, et al. Development and validation of a clinical prediction rule to identify suspected breast cancer: a prospective cohort study. BMC Cancer 2014 Oct 3;14:743. doi: 10.1186/1471-2407-14-743
- Breast cancer (Gail model)
LOE 2b
Decision Support Tools, 1-Sep-1994
Based on the results of Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. JNCI 1989; 81: 1879-86.
- Colorectal cancer: risk of advanced neoplasia
LOE 1a
Decision Support Tools, 1-Nov-2016
Based on the results of Schroy PC, Wong JB, O'Brien MJ, et al. A risk prediction index for advanced colorectal neoplasia at screening colonoscopy. Am J Gastroenterol 2015; 110: 1062-71.
- Esophageal cancer risk with dysphagia
LOE 1a
Decision Support Tools, 3-Jun-2011
Based on the results of Rhatigan E, Tyrmpas I, Murray G, Plevris JN. Scoring system to identify patients at high risk of oesophageal cancer. Br J Surg 2010; 97: 1831-7.
- Hepatic metastasis from CRC prognosis
LOE 1a
Decision Support Tools, 1-Jun-2010
Based on the results of Minagawa M, Yamamoto J, Kosuge T, et al. Simplified staging system for predicting prognosis in patients with resectable liver metastasis. Arch Surg 2007; 142: 269-76
- Lung CA: COPD Lung Cancer Screening Score
LOE 1a
Decision Support Tools, 2-Jul-2015
Based on the results of de-Torres JP, Wilson DO, Sanchez-Salcedo P, et al. Lung cancer in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 191: 285-91.
- Lung cancer
LOE 2b
Decision Support Tools, 1-Sep-2003
Based on the results of Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. JNCI 2003; 95: 470-8.
- Malignancy risk with asymptomatic microscopic hematuria
LOE 1a
Decision Support Tools, 2-Jul-2013
Based on the results of Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc 2013; 88: 129-38.
- Ovarian cancer risk (Harvard)
LOE 2b
Decision Support Tools, 1-Sep-2004
Based on the results of Kim DJ, Rockhill B, Colditz GA. Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol 2004; 57: 332-40.
- Ovarian cancer risk (SEER)
LOE 2a
Decision Support Tools, 1-Aug-2006
Based on the results of Hartge P, Whittemore AS, Itnyre J, et al. Rates and risks of ovarian cancer in subgroup of white women in the United States. Obstet Gynecol 1994; 84: 760-4.
- Pancreatic cancer
LOE 2b
Decision Support Tools, 1-Sep-2004
Based on the results of Kim DJ, Rockhill B, Colditz GA. Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol 2004; 57: 332-40.
- Pedigree Assessment Tool for BRCA risk assessment (PAT)
LOE 1a
Decision Support Tools, 2-Jul-2013
Based on the results of Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer 2006; 107: 1769-76
- Proximal colon cancer
LOE 1a
Decision Support Tools, 1-Jun-2004
Based on the results of Imperiale TF, Wagner DR, Lin CY, et al. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 2003; 139: 959-65.
- Pulmonary nodule (PET + Swensen rule)
LOE 1a
Decision Support Tools, 1-Dec-2005
Based on the results of Herder GJ, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005; 128: 2490-6.
- Pulmonary nodule (Swensen rule)
LOE 1a
Decision Support Tools, 1-Dec-2005
Based on the results of Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Arch Intern Med 1997; 157: 949-55.
- Risk of colorectal cancer in symptomatic patients using FIT
LOE 1a
Decision Support Tools, 1-Jun-2017
Based on the results of Cubiella J, Vega P, Salve M, et al. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients. BMC Medicine 2016; 14: 128
- Risk of hepatocellular cancer in patients with hepatitis C
LOE 1A
Decision Support Tools, 1-Jun-2018
Based on the results of Xing J, Spradling PR, Moorman AC, et al. A point system to forecast hepatocellular carcinoma risk before and after treatment among persons with chronic hepatitis C. Dig Dis Sci 2017; 62: 3221-34.
